常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.91/0.06
|
企业价值
107.09M
|
资产负债 |
每股账面净值
0.37
|
现金流量 |
现金流量率
--
|
损益表 |
收益
24.52M
|
每股收益
0.35
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|

同行比较之报价最少15分钟延迟
业务概览
|
|||
ImmunoPrecise Antibodies Ltd is an AI-driven biotherapeutic research, technology and scientifically robust life science company focused on the discovery and development of next-generation biologics. The Company combines scientific expertise with proprietary technologies such as its LENSai platform to accelerate drug discovery and improve decision-making across complex biological systems. IPA has several subsidiaries in North America and Europe, supporting global partners inadvancing novel therapeutics, diagnostics, and translational research. |